Improved Tolerability of De Novo Letermovir Over Valganciclovir for Cytomegalovirus Prophylaxis in Seropositive Liver Transplant Recipients.

Valcyte (valganciclovir) - Roche, Tanabe Pharma

Prevymis (letermovir) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/42295027

Chris M Saddler; David Al-Adra; Hanna L Kleiboeker; Jillian L Descourouez; John P Rice; Margaret R Jorgenson

Jun 16, 2026